Inherited calcium channelopathies in the pathophysiology of arrhythmias

Luigi Venetucci1, Marco Denegri, Carlo Napolitano

  • 1Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri, Via Maugeri 10/10a, Pavia 27100, Italy.

Insights

Genetic mutations in cardiac calcium regulation proteins cause life-threatening arrhythmias. Understanding these calcium-handling diseases improves knowledge of heart physiology and disease mechanisms.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Genetics of Cardiac Arrhythmias

Background:

  • Cardiac calcium flux is critical for heart excitability and contractility.
  • Altered calcium regulation is linked to heart disease, contractile dysfunction, and arrhythmias.
  • Genetic abnormalities in calcium-handling proteins are increasingly recognized as causes of inherited arrhythmias.

Purpose of the Study:

  • To review the structure and function of key cardiac calcium-handling proteins.
  • To elucidate mechanisms by which mutations in these proteins lead to specific clinical phenotypes.
  • To provide an overview of genetic calcium-handling diseases and their impact on cardiac function.

Main Methods:

  • Review of scientific literature on calcium-handling proteins and cardiac arrhythmias.
  • Analysis of gene mutations in ryanodine receptor 2 (RYR2), calsequestrin 2 (CASQ2), and L-type calcium channel proteins.
  • Correlation of identified mutations with clinical phenotypes such as CPVT, Timothy syndrome, Brugada syndrome, and early repolarization syndrome.

Main Results:

  • Mutations in RYR2 and CASQ2 are associated with catecholaminergic polymorphic ventricular tachycardia (CPVT).
  • Defects in L-type calcium channel genes cause diverse arrhythmias, including Timothy syndrome, Brugada syndrome, and early repolarization syndrome.
  • Identification of specific gene mutations clarifies the role of calcium dysregulation in cardiac disease.

Conclusions:

  • Genetic mutations in cardiac calcium-handling proteins are a significant cause of inherited arrhythmias.
  • Understanding these mutations provides insights into the pathophysiology of cardiac excitability and contractility.
  • This knowledge advances the diagnosis and potential treatment strategies for calcium-handling diseases.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...